| 2 min read
Aberdeen clinical research centre widens access to clinical trials across Scotland, advancing early Alzheimer’s research
| 2 min read
Well-calibrated metrics reveal that AI virtual cells can reliably identify biologically significant signals and accelerate target discovery pipelines.
| 2 min read
The acquisition brings together two leaders in scientific software to provide end-to-end support from molecular design and analytical characterization to manufacturing quality control.Industry Perspectives
| 2 min read
A collaborative effort to co-develop scalable and reproducible sample preparation workflows for proteomics
| 2 min read
Paired with OGT’s Interpret platform, the solution allows labs to visualise MRD dynamics over time and streamline workflows while maintaining accuracy and reproducibility.
| 2 min read
Award-winner Cheng Lyu shows how tiny changes in circuit wiring can shift an animal’s behavior, illuminating the developmental rules of the nervous system.
| 2 min read
Qureight’s Vascul8 model uses AI to analyse CT scans and identify patients at risk of residual pulmonary hypertension after surgery.
| 2 min read
Lonza strengthens its pharmaceutical quality control portfolio through the acquisition of Redberry, enabling faster and more reliable microbial testing.
| 1 min read
Ongoing collaboration aims to bring new treatments for neurodegenerative conditions closer to patients.
| 3 min read
Ryvu’s ONCO Prime platform uncovers novel molecular vulnerabilities and actionable targets in colorectal and other cancers.
| 2 min read
Company is first to deliver ultra-long, fully verified DNA in less than 25 days, backed by the industry’s only on-time guarantee
| 2 min read
Under the new partnership, Biodesix will lead development and regulatory efforts for Bio-Rad’s ddPLEX ESR1 assay, enabling sensitive ctDNA-based mutation testing.
